Apoptosis, proliferative activity and Bcl-2 expression in Epstein-Barr- virus-positive non-Hodgkin's lymphomas

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 7, 1997, Pages 395-401

  Takano, Yasuo ^a   Saegusa, Makoto ^a   Masuda, Mitsunobu ^b   Mikami, Tetsuo ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yokohama City University   (Japan)

Author keywords

Apoptosis; Epstein Barr virus; Non Hodgkin's lymphoma

Indexed keywords

VIRUS RNA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER GROWTH; CARCINOGENESIS; CELL SURVIVAL; EPSTEIN BARR VIRUS; GENE DELETION; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0030796627     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01240123     Document Type: Article

References (34)

1. Chen ML, Tsai CN, Liang CL, Shu CN, Hang CR, Sulitzeann D, Linst ST, Chang YS (1992) Cloning and characterization of the latent membrane protein (LMP) of specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in Taiwanese population. Oncogene 7:2131-2140
2. Chen WG, Chen YY, Bacchi MM, Alvarenga M, Weiss LM (1996) Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalance of deletions within the latent membrane protein gene. Am J Pathol 148:17-23
3. Columbano A, Ledda-Columbano GM, Rao PM, Rajalakshmi S, Sarma DSR (1984) Occurrence of cell death (apoptosis) in preneoplastic and neoplastic cells: a sequential study. Am J Pathol 116:441-446
4. Fingeroth JD, Weiss JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510-4514
5. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM (1995) Post-transplantation lymphoproliferalive disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396-1403
6. Gregory CD, Dive C, Henderson S, Smith C, Williams GT, Gordon J, et al (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612-614
7. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, Pedersen C (1991) AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 138:149-163
8. Hamilton-Dutoit SJ, Pallesen G (1992) A survey of Epstein-Barr gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Pathol 335:128-130
9. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickenson A (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115
10. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ (1991) BCL-2 protein is topographically restricted in tissues by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965
11. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Weinberg G (1993) Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP-1. Oncogene 8:1573-1583
12. Kanavaros P, Briere J, Lescs MC, Gaulard P (1996) Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localisation and expression of NK and/or T cell antigens by tumour cells. J Pathol 178:297-302
13. Kerr JFR, Winterford CM, Harmon BV (1994) Apoptosis: its significance in cancer and cancer therapy. Cancer 73:2013-2026
14. Kieff E, Liebowitz D (1990) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM (eds) Virology. Raven, New York, pp 1889-1920
15. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS (1995) The association of Epstein-Barr virus with smooth-muscle tumours occurring after organ transplantation. N Engl J Med 332:19-25
16. Leonichi L, Del Vecchio MT, Barbini P, Galieni P, Pileri S, Sabattini E, Gherlinzoni F, Tosi P, Kraft R, Cottier H (1993) Correlation between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 142:755-763
17. Nathwani BN, Brynes RK, Lincolin T, Hansmann ML (1992) Classification of non-Hodgkin's lymphomas. In: Knowles DM (ed) Neoplastic haematology. Williams & Wilkins, Baltimore. Md, pp 555-601
18. Purtilo DT, Strobach RS, Okano M, Davis JR (1992) Biology of disease: Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 67:5-23
19. Raff MC (1992) Social control of cell survival and cell death. Nature 356:357-400
20. Rickinson AB, Young LS, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA-2 on the growth phenotype of virus-transformed B cells. J Virol 61:1310-1317
21. Rowe M, Rowe DT, Gregory CD, Young LS, Farrel PJ, Rupani H, Rickenson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743-2751
22. Sculley TB, Apollini A, Hurren L, Moss DE, Cooper D (1990) Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 162:643-648
23. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214
24. Purtilo DT, Strobach RS, Okano M, Davis JR (1992) Biology of disease: Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 67:5-23
25. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickenson AB (1990) Epstein-Barr virus type 1, and 2 differ in the EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 64:4084-4092
26. Takano Y, Kato Y (1995) Epstein-Barr virus association with early cancers found together with gastric medullary carcinomas demonstrating lymphoid infiltration. J Pathol 175:39-44
27. Takano Y, Colanzi RP, Shiga J (1994) High incidence of Epstein-Barr virus associated non-Hodgkin's lymphomas in the Bolivian mountains. Pathol Int 44:237-240
28. Takano Y, Saegusa M, Ikenaga M, Mitomi H, Okayasu I (1996) Apoptosis of colon cancer: comparison with Ki-67 proliferative activity and expression of p53. J Cancer Res Clin Oncol 122:166-170
29. Takano Y, Saegusa M, Ikenaga M, Okayasu I (1997) Apoptosis and proliferative activity of non-Hodgkin's lymphomas: comparison with expression of bcl-2, p53 and c-myc proteins. Pathol Int 47:90-94
30. Theodorou I, Bigorgne C, Delfau MH, Lahet C, Cochet G, Vidard M, Raphael M, Gaulard P, Farcet JP (1996) Vj rearrangement of the TCRy locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturing gradient gel electrophoresis. J Pathol 178:303-310
31. Tsujimoto Y, Ikegami N, Crose CM (1987) Characterisation of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 2:3-7
32. Yonishi-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Orem M (1991) Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 352:345-347
33. Young LS, Rowe M (1992) Epstein-Barr virus, lymphomas and Hodgkin's disease. Semin Cancer Biol 3:273-284
34. Young LS, Yao QY, Roponey CM, Sculley TB, Moss DJ, Rupani H, Laux G, Mornkamm GW (1987) New type B isolate of Epstein-Barr virus from Burkitt's lymphoma and normal individuals in an endemic area. J Gen Viol 68:2853-2862